Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Related Articles by Review for PubMed (Select 10577333)

1.

Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection.

Baffis V, Shrier I, Sherker AH, Szilagyi A.

Ann Intern Med. 1999 Nov 2;131(9):696-701. Review.

PMID:
10577333
2.

[Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].

Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Takemura S, Shiomi S, Kinoshita H.

Gan To Kagaku Ryoho. 2001 Dec;28(13):1975-9. Review. Japanese.

PMID:
11791377
3.

HCV-hepatocellular carcinoma: new findings and hope for effective treatment.

Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.

Microsc Res Tech. 2005 Nov;68(3-4):130-48. Review.

PMID:
16276514
4.

What surgeons should know about viral hepatitis and hepatocellular carcinoma.

Hassoun Z, Gores GJ.

Surg Oncol Clin N Am. 2003 Jan;12(1):1-11, vii. Review.

PMID:
12735125
5.

Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.

Omata M, Yoshida H, Shiratori Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3. Review.

PMID:
16234063
6.
7.
8.

Liver cancer and its prevention.

Tsukuma H, Tanaka H, Ajiki W, Oshima A.

Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):244-50. Review.

9.

Treatment of hepatitis C: critical appraisal of the evidence.

Cammà C, Licata A, Cabibbo G, Latteri F, Craxì A.

Expert Opin Pharmacother. 2005 Mar;6(3):399-408. Review.

PMID:
15794731
10.

Prevention of hepatitis C virus-related hepatocellular carcinoma.

Heathcote EJ.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S294-302. Review.

PMID:
15508097
11.

Prevention of hepatitis B virus-related hepatocellular carcinoma.

Lok AS.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S303-9. Review.

PMID:
15508098
12.

Hepatitis B virus vaccine for patients with hepatitis C virus infection.

Chlabicz S, Grzeszczuk A.

Infection. 2000 Nov-Dec;28(6):341-5. Review.

PMID:
11139151
13.

The epidemiology and prevention of hepatocellular carcinoma.

Monto A, Wright TL.

Semin Oncol. 2001 Oct;28(5):441-9. Review.

PMID:
11685737
14.

Interferon alfa in the treatment of chronic viral hepatitis B and C.

Woo MH, Burnakis TG.

Ann Pharmacother. 1997 Mar;31(3):330-7. Review.

PMID:
9066942
15.

Prevention of hepatocellular carcinoma complicating chronic hepatitis C.

Ueno Y, Sollano JD, Farrell GC.

J Gastroenterol Hepatol. 2009 Apr;24(4):531-6. doi: 10.1111/j.1440-1746.2009.05814.x. Review.

PMID:
19368633
16.

Current strategies for chemoprevention of hepatocellular carcinoma.

Okita K, Sakaida I, Hino K.

Oncology. 2002;62 Suppl 1:24-8. Review.

PMID:
11868781
17.

Long-term effects of interferon-based therapy for chronic hepatitis C.

Yu ML, Huang CF, Dai CY, Huang JF, Chuang WL.

Oncology. 2007;72 Suppl 1:16-23. Epub 2007 Dec 13. Review.

PMID:
18087178
18.

Natural history of hepatitis-related hepatocellular carcinoma.

But DY, Lai CL, Yuen MF.

World J Gastroenterol. 2008 Mar 21;14(11):1652-6. Review.

19.

Interferon treatment of cirrhotic patients with chronic hepatitis C.

Idilman R, De Maria N, Colantoni A, Dokmeci A, Van Thiel DH.

J Viral Hepat. 1997 Mar;4(2):81-91. Review.

PMID:
9097263
20.

Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma.

Rasi G, Pierimarchi P, Sinibaldi Vallebona P, Colella F, Garaci E.

Int Immunopharmacol. 2003 Aug;3(8):1169-76. Review.

PMID:
12860172
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk